HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Erkki Ruoslahti Selected Research

N-end cysteine peptide tumor-homing peptide

1/2017In vivo cation exchange in quantum dots for tumor-specific imaging.
10/2016iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes.
1/2015Tumor-penetrating iRGD peptide inhibits metastasis.
1/2013De novo design of a tumor-penetrating peptide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Erkki Ruoslahti Research Topics

Disease

89Neoplasms (Cancer)
06/2021 - 02/2002
14Breast Neoplasms (Breast Cancer)
11/2017 - 02/2002
10Neoplasm Metastasis (Metastasis)
06/2021 - 04/2004
8Carcinoma (Carcinomatosis)
01/2021 - 11/2003
6Prostatic Neoplasms (Prostate Cancer)
06/2021 - 02/2002
6Atherosclerotic Plaque (Atheroma)
04/2016 - 06/2009
5Peritoneal Neoplasms
08/2019 - 08/2015
5Ovarian Neoplasms (Ovarian Cancer)
08/2019 - 08/2012
4Infections
01/2021 - 09/2017
4Glioblastoma (Glioblastoma Multiforme)
11/2020 - 10/2011
4Melanoma (Melanoma, Malignant)
11/2017 - 06/2006
4Wounds and Injuries (Trauma)
03/2013 - 02/2006
3Fibrosis (Cirrhosis)
01/2019 - 12/2010
3Atherosclerosis
01/2016 - 06/2009
3Thrombosis (Thrombus)
10/2014 - 12/2009
2Adenocarcinoma
01/2021 - 05/2017
2Brain Neoplasms (Brain Tumor)
11/2020 - 01/2019
2Alzheimer Disease (Alzheimer's Disease)
01/2018 - 11/2017
2Rupture
11/2017 - 06/2009
2Hypoxia (Hypoxemia)
02/2014 - 06/2011
2Pulmonary Arterial Hypertension
02/2014 - 06/2011
2Cicatrix (Scar)
03/2013 - 12/2010
2Carcinogenesis
11/2003 - 11/2003
1Bacterial Infections (Bacterial Infection)
01/2021
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2021
1Necrosis
12/2019
1Staphylococcal Infections
02/2018
1Abdominal Aortic Aneurysm
11/2017
1Gliosis
11/2017
1Neuroinflammatory Diseases
11/2017
1Glioma (Gliomas)
11/2017

Drug/Important Bio-Agent (IBA)

76Peptides (Polypeptides)IBA
06/2021 - 02/2002
17Pharmaceutical PreparationsIBA
01/2021 - 11/2002
15Proteins (Proteins, Gene)FDA Link
11/2020 - 05/2002
10LigandsIBA
12/2019 - 01/2004
10AntibodiesIBA
10/2019 - 11/2003
9Fluorescein (Funduscein)FDA LinkGeneric
08/2015 - 05/2002
8IntegrinsIBA
01/2021 - 08/2002
6SiliconIBA
01/2021 - 11/2010
6ferric oxide (iron oxide)IBA
01/2019 - 05/2008
6Neuropilin-1IBA
10/2016 - 12/2009
5Blood Proteins (Serum Proteins)IBA
01/2013 - 02/2006
5FibrinIBA
01/2013 - 02/2006
4Liposomes (Liposome)IBA
06/2021 - 01/2007
4Small Interfering RNA (siRNA)IBA
08/2019 - 04/2004
4DecorinIBA
01/2019 - 12/2010
4N-end cysteine peptide tumor-homing peptideIBA
01/2017 - 01/2013
4Peptide Hydrolases (Proteases)FDA Link
01/2016 - 06/2009
4Doxorubicin (Adriamycin)FDA LinkGeneric
08/2015 - 01/2010
4AntigensIBA
05/2015 - 02/2011
4Antineoplastic Agents (Antineoplastics)IBA
01/2015 - 12/2009
4Membrane Proteins (Integral Membrane Proteins)IBA
02/2011 - 04/2004
4Peptide LibraryIBA
08/2007 - 07/2002
3SolutionsIBA
01/2021 - 01/2013
3Paclitaxel (Taxol)FDA LinkGeneric
10/2016 - 03/2009
3Albumin-Bound PaclitaxelFDA Link
10/2016 - 03/2009
3Apolipoproteins E (ApoE)IBA
01/2016 - 06/2009
3MicellesIBA
10/2014 - 03/2009
3cysteinyl-arginyl-glutamyl-lysyl-alanylIBA
01/2013 - 06/2009
3Fibronectins (Fibronectin)IBA
06/2010 - 09/2003
3Arginine (L-Arginine)FDA Link
09/2009 - 06/2009
3NucleolinIBA
09/2009 - 11/2003
3LyP-1 peptideIBA
09/2008 - 07/2002
2Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 02/2018
2cysteinylglycine (Cys-Gly)IBA
01/2016 - 01/2010
2Therapeutic UsesIBA
09/2015 - 10/2011
2NeuropilinsIBA
08/2015 - 01/2015
2Tumor Biomarkers (Tumor Markers)IBA
05/2015 - 08/2013
2Biological ProductsIBA
01/2015 - 06/2013
2Cysteine (L-Cysteine)FDA Link
02/2014 - 06/2009
2Glucose (Dextrose)FDA LinkGeneric
12/2013 - 03/2010
2Amino AcidsFDA Link
01/2010 - 06/2009
2Lysine (L-Lysine)FDA Link
09/2009 - 06/2009
2matrigelIBA
01/2009 - 11/2003
1Androgen Receptors (Androgen Receptor)IBA
06/2021
1Antisense OligonucleotidesIBA
06/2021
1antiglomerular basement membrane antibodyIBA
11/2020
1nidogen (entactin)IBA
12/2019
1Laminin (Merosin)IBA
12/2019
1CytokinesIBA
12/2019
1Retinoid X Receptor betaIBA
10/2019
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
10/2019
1Cisplatin (Platino)FDA LinkGeneric
08/2019
1LipidsIBA
08/2019
1MicroRNAs (MicroRNA)IBA
07/2019
1locked nucleic acidIBA
07/2019
1AntagomirsIBA
07/2019
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2019
1VancomycinFDA LinkGeneric
02/2018
1KLA peptideIBA
12/2017
1Mannose ReceptorIBA
11/2017
1Anti-Infective Agents (Microbicides)IBA
09/2017

Therapy/Procedure

32Therapeutics
01/2021 - 02/2002
3Precision Medicine
12/2017 - 10/2010
3Quantum Dots (Quantum Dot)
01/2017 - 09/2007
2Investigational Therapies (Experimental Therapy)
01/2017 - 01/2016
2Drug Therapy (Chemotherapy)
01/2016 - 08/2015
2Intravenous Administration
06/2011 - 08/2008
1Immunotherapy
01/2021
1Micro-Electrical-Mechanical Systems
11/2017